SWP
FBRX icon

Stratos Wealth Partners’s Forte Biosciences FBRX Stock Holding History

Stratos Wealth Partners’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27
Closed -$7K – 991
2019
Q3 		$7K Sell
27
-4
-13% -$6.07K ﹤0.01% 959
2019
Q2 		$76K Hold
31
– – ﹤0.01% 929
2019
Q1 		$124K Hold
31
– – 0.01% 892
2018
Q4 		$94K Buy
31
+3
+11% +$12.9K ﹤0.01% 838
2018
Q3 		$164K Hold
28
– – 0.01% 925
2018
Q2 		$98K Hold
28
– – ﹤0.01% 943
2018
Q1 		$124K Hold
28
– – 0.01% 1082
2017
Q4 		$108K Buy
+28
New +$112K ﹤0.01% 1150

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stratos Wealth Partners's FBRX Position: Q4 2019 in Review

Stratos Wealth Partners sold out of Forte Biosciences (FBRX) in Q4 2019, closing a stake of 27 shares — an estimated $7K sold.

Stratos Wealth Partners first reported a position in FBRX in Q4 2017 and held it in 8 quarters. The position peaked at $164K in Q3 2018. 51 funds tracked by Wall St. Rank hold FBRX as of Q4 2019.

  • Stratos Wealth Partners reported no remaining Forte Biosciences position as of Q4 2019 after selling out during the quarter.
  • Stratos Wealth Partners sold 27 Forte Biosciences shares in Q4 2019, an estimated $7K.
  • Stratos Wealth Partners first reported a position in Forte Biosciences in Q4 2017 and held it in 8 quarters.
  • Stratos Wealth Partners's Forte Biosciences position peaked at $164K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2019.

Based on Stratos Wealth Partners's 13F filing for Q4 2019, filed 29 Jan 2020.